PUBLIC CONTRACT · 2022

Agre. Centralizada goserelina 10.8 mg ser implante; goserelina 3.6 mg; palivizumab (P259-2021-126)

Contract value: €94,247.50
Signed on: 15 March 2022
Procedure: Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9139955

PUBLISHED SUBJECT

Convite ao abrigo do(s) acordo(s)-quadro 2021/6, 2021/12 e 2021/47 para suprir necessidades na área da saúde

Parties involved

Contracting body: CHBM - Centro Hospital Barreiro Montijo, EPE
Awardee: ASTRAZENECA PRODUTOS FARMACÊUTICOS, LDA
Place of performance: Portugal, Setúbal, Barreiro
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: ASTRAZENECA PRODUTOS FARMACÊUTICOS, LDA · Tax ID 502942240
Bidder: LILLY PORTUGAL-PROD.FARMAC.LDA · Tax ID 500165602
Bidder: GENERIS FARMACÊUTICA, S.A. · Tax ID 508107997

Values and timeline

Contract price: €94,247.50
Procedure base price: €34,357,072.75
Total effective price: €94,247.50
Publication date: 23 March 2022
Award date: 15 March 2022
Signing date: 15 March 2022
Performance period: 337 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion: Monofator
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 259.º do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement: CP 2021/6 - Medicamentos do foro oncológico e imunomoduladores
Centralised procedure: Yes
Environmental criterion: No
Notice: Not stated
Procedure identifier: 5741778

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts